Status:
COMPLETED
Stroke Rehabilitation Outcome During COVID-19 Lockdown
Lead Sponsor:
Jeremia Held
Conditions:
Stroke
Rehabilitation
Eligibility:
All Genders
18+ years
Brief Summary
COVID-19 has a big impact on individuals and society as a whole. Especially persons with (multiple) comorbidities such as stroke are affected. The impact of COVID-19 on stroke rehabilitation delivery ...
Detailed Description
With 16'000 patients hospitalized and with new permanent disability in approximately 7'000 individuals every year in Switzerland, stroke has a major impact on quality of life and is an enormous socioe...
Eligibility Criteria
Inclusion
- Ischemic or haemorrhagic stroke, confirmed by MRI-DWI and/or CT
- Participating in a stroke research project before the Lockdown (ESTREL - BASEC Nr. 2018-02021/ RE-USE - BASEC-Nr. 2017-01070)
- Age 18 years or older
- Verbal and written informed consent of the patient after participants' information
Exclusion
- Severe communication or cognitive deficits, that cause inability to follow the procedures
Key Trial Info
Start Date :
April 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 12 2020
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04373109
Start Date
April 16 2020
End Date
October 12 2020
Last Update
October 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland, 8091